Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine

[摘要]：Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic apparatus. We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family. We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内